Books in a Library

interferon

Thyroid Dysfunction Related to Interferon in Turkish Patients with Viral Hepatitis: Incidence and Influencing Factors

DOI: 
10.7727/wimj.2016.141
Synopsis: 
Although TD secondary to interferon treatment in patients with CHB-C may develop in a substantial rate, most of these are temporary and do not require TD treatment. Independent risk factors in TD development were found to be gender and age.

ABSTRACT

Objective: Interferon therapy is widely used for patients with chronic viral hepatitis B and C (CHB-C). It is known that thyroid gland dysfunction (TD) may develop secondary to interferon treatment, but different frequencies of TD development are reported in the literature. For this reason, we aimed to investigate the incidence of TD developing secondary to interferon treatment in patients with CHB-C treated in our clinic and possible influence factors.

Accepted: 
15 Jun, 2016
PDF Attachment: 
Journal Sections: 
Journal Authors: 
e-Published: 15 Jul, 2016

Disclaimer

Manuscripts that are “Published at Acceptance” have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear prior to being copy edited or formatted in the style guide of this Journal. The contents of the manuscript may change before it is published in its final form. While accepted manuscripts are not yet assigned a volume, issue, or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. Manuscripts in this section will be removed once they have been assigned to a volume and issue, but will still retain the DOI and date of e-publication.

Subscribe to RSS - interferon